In a collaboration between the Swedish Medical Products Agency (MPA; Läkemedelsverket) and Swedish Work Environment Authority (Arbetsmiljöverket), a webinar will be held on June 2nd regarding clinical trials of medicinal products containing or consisting of genetically modified organisms (GMOs) or genetically modified microorganisms (GMMs).
The Swedish MPA is the supervisory authority for so-called deliberate release of medicinal products containing or consisting of GMOs, while the Swedish Work Environment Authority is the supervisory authority for so-called contained use of GMMs. Learn more in English or Swedish.
The webinar will be held in Swedish: Klinisk prövning av läkemedel som innehåller eller består av genetiskt modifierade (mikro-) organismer on the 02 June 2022, 9-10am (Swedish time)
Do you need support planning a clinical trial? From standalone services to full-service solutions, SCRO support you with clinical development of your medicinal product from start to finish.
